BAXTER INTERNATIONAL INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
BAXTER INTERNATIONAL INC. (BAX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $54.86 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-02-12
- BAXTER INTERNATIONAL INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $54.86, a 15.87% decline from fiscal 2024.
- BAXTER INTERNATIONAL INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $65.21, a 5.98% decline from fiscal 2023.
- BAXTER INTERNATIONAL INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $69.36, a 3.18% decline from fiscal 2022.
- BAXTER INTERNATIONAL INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $71.64, a 33.28% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $54.86 10-K · filed 2026-02-12 |
| 2024-12-31 | $65.21 10-K · filed 2025-02-21 |
| 2023-12-31 | $69.36 10-K · filed 2024-02-08 |
| 2022-12-31 | $71.64 10-K · filed 2023-02-09 |
| 2021-12-31 | $53.75 10-K · filed 2022-02-23 |
| 2020-12-31 | $41.42 8-K · filed 2021-04-29 |
| 2019-12-31 | $46.44 10-K · filed 2020-03-17 |
| 2018-12-31 | $33.98 10-K · filed 2019-02-21 |
| 2017-12-31 | $34.25 8-K · filed 2018-08-23 |
| 2016-12-31 | $32.87 10-K · filed 2017-02-23 |
| 2015-12-31 | $44.67 10-K · filed 2016-02-26 |
| 2014-12-31 | $49.21 10-K · filed 2015-02-26 |
| 2013-12-31 | $40.26 10-K · filed 2014-02-21 |
| 2012-12-31 | $57.47 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |